Companies 0 See All

Hedge Funds 0 See All

Insiders 0 See All

Institutional Investors 0 See All

Click here to see all results for

Home > Insider Trading > Filing (0001387131-15-000444)

Filing Details

Accession Number:: 0001387131-15-000444
Form Type:: 4
Zero Holdings:: No
Publication Time:: 2015-02-10 15:55:27
Reporting Period:: 2015-02-06

Filing Date:: 2015-02-10
Accepted Time:: 2015-02-10 15:55:27
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1173281	Ohr Pharmaceutical Inc	OHRP	Pharmaceutical Preparations (2834)	465622433

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1579887	Samuel Backenroth	C/O Ohr Pharmaceutical, Inc. 800 Third Ave., 11Th Floor New York NY 10022	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock, Par Value $0.0001 Per Share	Acquisiton	2015-02-06	1,500	$6.75	6,199	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Show Other Fields >>

Sec. Name	Sec. Type	Price	Date	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Option	$1.50	2010-04-12	2015-04-12	66,667	66,667	Direct
Common Stock	Option	$1.71	2014-03-09	2017-03-09	133,333	133,333	Direct
Common Stock	Option	$10.11	2014-02-03	2017-02-03	250,000	250,000	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2015-04-12	66,667	66,667	Direct
2017-03-09	133,333	133,333	Direct
2017-02-03	250,000	250,000	Direct

Footnotes

All exercisable.
33,333 options are currently unexercisable until March 9, 2015.
125,000 options are currently unexercisable; half will become exercisable February 3, 2015 and half will become exercisable February 3, 2016.